Gilead Sciences (GILD) Tax Rate Growth (5y) (2014 - 2026)

Gilead Sciences (GILD) Tax Rate Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -227.00
Dec 31, 2025 -3,654.00
Sep 30, 2025 -4,104.00
Jun 30, 2025 3,181.00
Mar 31, 2025 -296.00
Dec 31, 2024 -4,536.00
Sep 30, 2024 -5,325.00
Jun 30, 2024 -86.00
Mar 31, 2024 -923.00
Dec 31, 2023 -4,354.00
Sep 30, 2023 -1,491.00
Jun 30, 2023 2,177.00
Mar 31, 2023 1.00
Dec 31, 2022 -25,322.00
Sep 30, 2022 44.00
Jun 30, 2022 -93.00
Mar 31, 2022 8,251.00
Dec 31, 2021 2,952.00
Sep 30, 2021 254.00
Jun 30, 2021 -399.00